Search Results

There are 27925 results for: content related to: Safety and immunogenicity of co-administered MF 59-adjuvanted 2009 pandemic and plain 2009–10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals

  1. Impact of squalene-based adjuvanted influenza vaccination on graft outcome in kidney transplant recipients

    Transplant Infectious Disease

    Volume 17, Issue 2, April 2015, Pages: 314–321, M. Fernández-Ruiz, C. Lumbreras, M.P. Arrazola, F. López-Medrano, A. Andrés, J.M. Morales, J.R. de Juanes and J.M. Aguado

    Version of Record online : 2 MAR 2015, DOI: 10.1111/tid.12355

  2. You have full text access to this Open Access content
    The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine

    Influenza and Other Respiratory Viruses

    Volume 6, Issue 2, March 2012, Pages: 90–100, Signe C. Svindland, Åsne Jul-Larsen, Rishi Pathirana, Solveig Andersen, Abdullah Madhun, Emanuele Montomoli, Inderjit Jabbal-Gill and Rebecca J. Cox

    Version of Record online : 12 JUL 2011, DOI: 10.1111/j.1750-2659.2011.00271.x

  3. Antibody response to the non-adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients

    Transplant Infectious Disease

    Volume 14, Issue 6, December 2012, Pages: 564–574, M.J.C. Salles, Y.A.S. Sens, P. Malafronte, J.F. Souza, L.S. Vilas Boas and C.M. Machado

    Version of Record online : 13 AUG 2012, DOI: 10.1111/j.1399-3062.2012.00769.x

  4. Non-clinical safety and biodistribution of AS03-adjuvanted inactivated pandemic influenza vaccines

    Journal of Applied Toxicology

    Volume 35, Issue 12, December 2015, Pages: 1564–1576, Lawrence Segal, Sandrine Wouters, Danielle Morelle, Gaëlle Gautier, Julien Le Gal, Thomas Martin, Frieke Kuper, Eric Destexhe, Arnaud M. Didierlaurent and Nathalie Garçon

    Version of Record online : 27 FEB 2015, DOI: 10.1002/jat.3130

  5. You have full text access to this Open Access content
    Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta-analysis

    Influenza and Other Respiratory Viruses

    Volume 5, Issue 5, September 2011, Pages: 299–305, J. Kevin Yin, Gulam Khandaker, Harunor Rashid, Leon Heron, Iman Ridda and Robert Booy

    Version of Record online : 21 MAR 2011, DOI: 10.1111/j.1750-2659.2011.00229.x

  6. You have full text access to this OnlineOpen article
    Phase II, randomized, open, controlled study of AS03-adjuvanted H5N1 pre-pandemic influenza vaccine in children aged 3 to 9 years: follow-up of safety and immunogenicity persistence at 24 months post-vaccination

    Influenza and Other Respiratory Viruses

    Volume 9, Issue 2, March 2015, Pages: 68–77, Javier Díez-Domingo, José-María Baldó, Maria Victoria Planelles-Catarino, María Garcés-Sánchez, Isabel Ubeda, Angels Jubert–Rosich, Josep Marès, Pilar Garcia-Corbeira, Philippe Moris, Maurice Teko, Carline Vanden Abeele and Paul Gillard

    Version of Record online : 5 FEB 2015, DOI: 10.1111/irv.12295

  7. Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients

    Transplant Infectious Disease

    Volume 17, Issue 3, June 2015, Pages: 371–379, A. Ambati, S. Einarsdottir, I. Magalhaes, T. Poiret, R. Bodenstein, K. LeBlanc, M. Brune, M. Maeurer and P. Ljungman

    Version of Record online : 1 JUN 2015, DOI: 10.1111/tid.12382

  8. You have full text access to this Open Access content
    MF59®-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis

    Influenza and Other Respiratory Viruses

    Volume 2, Issue 6, November 2008, Pages: 243–249, Angelika Banzhoff, Michele Pellegrini, Giuseppe Del Giudice, Elena Fragapane, Nicola Groth and Audino Podda

    Version of Record online : 9 DEC 2008, DOI: 10.1111/j.1750-2659.2008.00059.x

  9. Influenza vaccine immunology

    Immunological Reviews

    Volume 239, Issue 1, January 2011, Pages: 167–177, Philip R. Dormitzer, Grazia Galli, Flora Castellino, Hana Golding, Surender Khurana, Giuseppe Del Giudice and Rino Rappuoli

    Version of Record online : 28 DEC 2010, DOI: 10.1111/j.1600-065X.2010.00974.x

  10. You have free access to this content
    De Novo Anti-HLA Antibody After Pandemic H1N1 and Seasonal Influenza Immunization in Kidney Transplant Recipients

    American Journal of Transplantation

    Volume 11, Issue 8, August 2011, Pages: 1727–1733, I. Katerinis, K. Hadaya, R. Duquesnoy, S. Ferrari-Lacraz, S. Meier, C. van Delden, P.-Y. Martin, C.-A. Siegrist and J. Villard

    Version of Record online : 14 JUN 2011, DOI: 10.1111/j.1600-6143.2011.03604.x

  11. You have full text access to this Open Access content
    Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals

    Influenza and Other Respiratory Viruses

    Volume 7, Issue 3, May 2013, Pages: 431–438, Mari Strengell, Niina Ikonen, Thedi Ziegler, Anu Kantele, Veli-Jukka Anttila and Ilkka Julkunen

    Version of Record online : 23 AUG 2012, DOI: 10.1111/j.1750-2659.2012.00415.x

  12. Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy-treated patients

    European Journal of Haematology

    Volume 90, Issue 5, May 2013, Pages: 413–419, Honar Cherif, Martin Höglund and Karlis Pauksens

    Version of Record online : 18 MAR 2013, DOI: 10.1111/ejh.12094

  13. Long-term and cross-reactive immunogenicity of inactivated trivalent influenza vaccine in the elderly: MF59-adjuvanted vaccine versus unadjuvanted vaccine

    Journal of Medical Virology

    Volume 85, Issue 9, September 2013, Pages: 1591–1597, Joon Young Song, Hee Jin Cheong, Ji Yun Noh, Yu Bin Seo, Won Suk Choi, Geum Joo Cho, Taik Gun Hwang and Woo Joo Kim

    Version of Record online : 12 JUL 2013, DOI: 10.1002/jmv.23630

  14. You have full text access to this OnlineOpen article
    A vaccine manufacturer’s approach to address medical needs related to seasonal and pandemic influenza viruses

    Influenza and Other Respiratory Viruses

    Volume 2, Issue 6, November 2008, Pages: 251–260, Benoit Baras, Nancy Bouveret, Jeanne-Marie Devaster, Louis Fries, Paul Gillard, Roland Sänger and Emmanuel Hanon

    Version of Record online : 9 DEC 2008, DOI: 10.1111/j.1750-2659.2008.00054.x

  15. You have free access to this content
    High Non-Specific T Lymphocyte Response to the Adjuvanted H1N1 Vaccine in Comparison with the H1N1/H3N2/B-Brisbane Vaccine without Adjuvant

    Scandinavian Journal of Immunology

    Volume 76, Issue 5, November 2012, Pages: 497–504, P. Korošec, M. Petrovec, M. Lainščak, P. Meško, M. Šilar and M. Košnik

    Version of Record online : 10 OCT 2012, DOI: 10.1111/j.1365-3083.2012.02763.x

  16. Evaluation of properties of chitosan as an adjuvant for inactivated influenza vaccines administered parenterally

    Journal of Medical Virology

    Volume 81, Issue 3, March 2009, Pages: 494–506, Yuri Ghendon, Stanislav Markushin, Yuri Vasiliev, Irina Akopova, Irina Koptiaeva, Georgy Krivtsov, Olga Borisova, Nelly Ahmatova, Ekaterina Kurbatova, Svetlana Mazurina and Valentina Gervazieva

    Version of Record online : 16 JAN 2009, DOI: 10.1002/jmv.21415

  17. You have full text access to this Open Access content
    An assessment of prime-boost vaccination schedules with AS03A-adjuvanted prepandemic H5N1 vaccines: a randomized study in European adults

    Influenza and Other Respiratory Viruses

    Volume 7, Issue 1, January 2013, Pages: 55–65, Paul Gillard, Adrian Caplanusi, Markus Knuf, François Roman, Karl Walravens, Philippe Moris, Mamadou Dramé and Tino F. Schwarz

    Version of Record online : 9 MAR 2012, DOI: 10.1111/j.1750-2659.2012.00349.x

  18. You have free access to this content
    Preventing influenza in younger children

    Clinical Microbiology and Infection

    Volume 18, Issue s5, October 2012, Pages: 42–49, S. Esposito, C. Tagliabue, L. Tagliaferri, M. Semino, M. R. Longo and N. Principi

    Version of Record online : 6 AUG 2012, DOI: 10.1111/j.1469-0691.2012.03942.x

  19. You have full text access to this Open Access content
    Matrix-M adjuvanted virosomal H5N1 vaccine confers protection against lethal viral challenge in a murine model

    Influenza and Other Respiratory Viruses

    Volume 5, Issue 6, November 2011, Pages: 426–437, Gabriel Pedersen, Diane Major, Sarah Roseby, John Wood, Abdullah S. Madhun and Rebecca J. Cox

    Version of Record online : 9 MAY 2011, DOI: 10.1111/j.1750-2659.2011.00256.x

  20. MF59 Is a Safe and Potent Vaccine Adjuvant for Flu Vaccines in Humans: What Did We Learn During Its Development?

    Clinical Pharmacology & Therapeutics

    Volume 82, Issue 6, December 2007, Pages: 740–744, D T O'Hagan, A Wack and A Podda

    Version of Record online : 31 OCT 2007, DOI: 10.1038/sj.clpt.6100402